132 related articles for article (PubMed ID: 3914816)
41. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
42. [Physiology and pathology of the entero-insular axis].
Creutzfeldt W
Schweiz Med Wochenschr; 1985 Jul; 115(29):970-3. PubMed ID: 3901250
[TBL] [Abstract][Full Text] [Related]
43. [Hormonal function of islands of Langerhans in diabetes mellitus].
Balabolkin MI; Abrikosova SIu
Probl Endokrinol (Mosk); 1984; 30(5):16-8. PubMed ID: 6390424
[TBL] [Abstract][Full Text] [Related]
44. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
[TBL] [Abstract][Full Text] [Related]
45. Dual effects of gastric inhibitory polypeptide on insulin secretion.
Opara EC; Go VL
Pancreas; 1993 Jan; 8(1):39-43. PubMed ID: 8419907
[TBL] [Abstract][Full Text] [Related]
46. C-peptide response to glycaemic stimuli.
Samal KC; Das S; Parija CR; Tripathy BB
J Assoc Physicians India; 1987 May; 35(5):362-4. PubMed ID: 3320022
[No Abstract] [Full Text] [Related]
47. Gastric inhibitory polypeptide and splanchnic blood perfusion: augmentation of the islet blood flow increase in hyperglycemic rats.
Svensson AM; Efendic S; Ostenson CG; Jansson L
Peptides; 1997; 18(7):1055-9. PubMed ID: 9357066
[TBL] [Abstract][Full Text] [Related]
48. An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice.
Hasib A; Ng MT; Gault VA; Khan D; Parthsarathy V; Flatt PR; Irwin N
Diabetologia; 2017 Mar; 60(3):541-552. PubMed ID: 28004148
[TBL] [Abstract][Full Text] [Related]
49. [From insulin secretion to insulin therapy].
Soltani D; Perlemuter L
Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
[No Abstract] [Full Text] [Related]
50. C-peptide used in the estimation of islet beta-cell function in diabetes.
Gjessing HJ
Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818
[No Abstract] [Full Text] [Related]
51. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
[TBL] [Abstract][Full Text] [Related]
52. Entero-insular axis and diabetes mellitus.
Creutzfeldt W
Horm Metab Res Suppl; 1992; 26():13-8. PubMed ID: 1490680
[TBL] [Abstract][Full Text] [Related]
53. Gastric inhibitory polypeptide: the neglected incretin revisited.
Meier JJ; Nauck MA; Schmidt WE; Gallwitz B
Regul Pept; 2002 Jul; 107(1-3):1-13. PubMed ID: 12137960
[TBL] [Abstract][Full Text] [Related]
54. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
55. Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreas.
Jensen SL; Holst JJ; Nielsen OV; Lauritsen KB
Acta Physiol Scand; 1981 Mar; 111(3):233-8. PubMed ID: 7032210
[TBL] [Abstract][Full Text] [Related]
56. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS; Ryan AS; Minaker KL; Elahi D
J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
[TBL] [Abstract][Full Text] [Related]
57. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
58. Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats.
Hinke SA; Gelling RW; Pederson RA; Manhart S; Nian C; Demuth HU; McIntosh CH
Diabetes; 2002 Mar; 51(3):652-61. PubMed ID: 11872663
[TBL] [Abstract][Full Text] [Related]
59. KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
Aaboe K; Knop FK; Vilsboll T; Vølund A; Simonsen U; Deacon CF; Madsbad S; Holst JJ; Krarup T
J Clin Endocrinol Metab; 2009 Feb; 94(2):603-8. PubMed ID: 19050053
[TBL] [Abstract][Full Text] [Related]
60. Studies of the entero-insular axis following pancreas transplantation in man: neural or hormonal control?
Clark JD; Wheatley T; Brons IG; Bloom SR; Calne RY
Diabet Med; 1989 Dec; 6(9):813-7. PubMed ID: 2533043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
